| |
| |
|
| Insider
Information: |
Jacobson Paul F |
| Relationship: |
Chief Executive Office... |
| City: |
Bedford |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
125,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$514,960 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
125,600 |
|
|
| Total
Value |
$514,960 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Director |
2008-10-23 |
125,600 |
2005-06-20 |
0 |
Premium* |
|
|
Thorne Healthtech, Inc. |
THRN |
Chief Executive Office... |
2023-10-16 |
0 |
2023-10-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-10-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,822,822) |
0 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-10-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,105,589) |
0 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-06-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
220,377 |
2,117,659 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-04-04 |
4/A |
D |
$4.72 |
$213,995 |
D/D |
(45,338) |
1,825,966 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-04-04 |
4 |
D |
$4.72 |
$191,424 |
D/D |
(40,556) |
1,838,036 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
2,338,036 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-03-24 |
4/A |
D |
$4.70 |
$281,563 |
D/D |
(59,907) |
1,871,304 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2023-03-24 |
4 |
D |
$4.70 |
$247,309 |
D/D |
(52,619) |
1,878,592 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2022-12-01 |
4 |
D |
$4.89 |
$221,703 |
D/D |
(45,338) |
1,931,211 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2022-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
450,000 |
1,976,549 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2022-03-31 |
4 |
OE |
$1.35 |
$67,415 |
D/D |
50,000 |
1,526,549 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2022-03-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,806) |
1,476,549 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
450,000 |
1,535,355 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2021-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
501,515 |
1,085,355 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive Officer |
• • • |
2021-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
501,515 |
0 |
0 |
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive OfficerOfficer |
• • • |
2021-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,602,445 |
|
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive OfficerOfficer |
• • • |
2021-09-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
583,840 |
|
- |
|
| THRN |
Thorne Healthtech, Inc. |
Chief Executive OfficerOfficer |
• • • |
2021-09-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
501,515 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2008-10-23 |
4 |
S |
$9.05 |
$244,458 |
D/D |
(27,000) |
125,600 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2008-10-22 |
4 |
S |
$9.39 |
$333,168 |
D/D |
(35,500) |
152,600 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2008-07-15 |
4 |
S |
$16.04 |
$160,350 |
D/D |
(10,000) |
188,000 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Director |
– • – |
2008-07-15 |
4 |
OE |
$4.41 |
$68,820 |
D/D |
10,000 |
190,500 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Co-Chairman |
– • – |
2005-06-20 |
4 |
S |
$19.85 |
$59,550 |
D/D |
(3,000) |
188,100 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
